Biotech

All Articles

Former Seagen chief executive officer unveils brand new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was marketed to Pfizer in 2013 for an immen...

Ironwood makes further purpose $1B GI drug with brand new subgroup records

.On the heels of a stage 3 succeed that failed to blow away capitalists, Ironwood Pharmaceuticals is...

Novartis inks $150M offer for autoimmune molecular adhesive

.Do not quit Monte Rosa Therapeutics right now. The Boston-based biotech is enjoying after authorizi...

Jade carves out exec staff with Chinook vets-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings as...

Septerna goes social along with upsized offering of $288M

.Commemorating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey F...

AbbVie creates Richter wealthier, paying out $25M to constitute finding contract

.AbbVie has actually gone back to the source of its antipsychotic powerhouse Vraylar looking for one...

GenSight gets into final full weeks of cash money path as earnings flow noses out of reach

.GenSight Biologics is actually full weeks far from lacking funds. Once more. The biotech only posse...

AZ licenses discarded rare condition medicine to Monopar Therapies

.Monopar Rehabs is actually recuperating a medication from the dump of AstraZeneca's uncommon diseas...

Arcus' brand new HIF-2a data in renal cancer cells mean prospective upper hand over Merck's Welireg, professionals state

.With new records out on Arcus Biosciences' experimental HIF-2a prevention, one team of experts figu...

Roche bets as much as $1B to extend Dyno genetics therapy shipping contract

.After developing a genetics treatment alliance along with Dyno Therapeutics in 2020, Roche is back ...